ClinicalTrials.Veeva

Menu

S90652 in Paediatric Hypertension

Servier logo

Servier

Status and phase

Completed
Phase 2

Conditions

Hypertension

Treatments

Drug: Perindopril

Study type

Interventional

Funder types

Other

Identifiers

NCT00202592
CL2-90652-002

Details and patient eligibility

About

The aim of the study is to assess the long-term safety and effects on blood pressure of a paediatric formulation of perindopril in hypertensive children

Enrollment

50 estimated patients

Sex

All

Ages

30 months to 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Hypertensive children, who have been treated for four months at least with S90652, with safety and efficacy

Exclusion criteria

  • Poorly controlled hypertension
  • Girls with signs of pubescence

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems